US Patent Issued to University of Massachusetts on May 12 for "Tumor-targeting, clearable human protein-based MRI nanoprobes, and compositions and methods thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,983, issued on May 12, was assigned to University of Massachusetts (Westborough, Mass.).

"Tumor-targeting, clearable human protein-based MRI nanoprobes, and compositions and methods thereof" was invented by Gang Han (Shrewsbury, Mass.) and Yang Zhao (Worcester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a novel class of clearable, tumor-targeting and human protein-based MRI nanoprobes and contrast agents and their compositions, and methods of preparation and use thereof."

The patent was filed on May 2, 2022, under Application No. 17/734,647.

*For further information, including images, charts and tables, please visit...